Palbociclib in advanced breast cancer: A cost-utility analysis

被引：0
|
作者：
Raphael, J. [1 ]
Helou, J. [1 ]
Naimark, D. M. [1 ]
机构：
[1] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1116P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cost-utility analysis of fulvestrant versus exemestane in the second line treatment of postmenopausal women with advanced breast cancer
    Ryan, J
    Hirsch, M
    Knight, H
    VALUE IN HEALTH, 2004, 7 (06) : 670 - 670
  • [22] COST-UTILITY ANALYSIS OF EXERCISE FOR THE PREVENTION OF CANCER
    O'Day, K.
    Campbell, D. J.
    VALUE IN HEALTH, 2016, 19 (07) : A740 - A740
  • [23] Cost-utility analysis of four common surgical treatment pathways for breast cancer
    Kouwenberg, Casimir A. E.
    Mureau, Marc A. M.
    Kranenburg, Leonieke W.
    Rakhorst, Hinne
    de Leeuw, Danielle
    Klem, Taco M. A. L.
    Koppert, Linetta B.
    Ramos, Isaac Corro
    Busschbach, Jan J.
    EJSO, 2021, 47 (06): : 1299 - 1308
  • [24] Cost-utility analysis
    Brown, GC
    Brown, MM
    Sharma, S
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 625 - 626
  • [25] COST-UTILITY ANALYSIS
    NICHOLLS, A
    BRITISH MEDICAL JOURNAL, 1993, 307 (6913): : 1213 - 1213
  • [26] RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
    Zou, Denise
    Niyazov, Alexander
    Arondekar, Bhakti
    Wu, Sherry
    BREAST, 2021, 60 : 302 - 302
  • [27] Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation
    Al-Ziftawi, Nour Hisham
    Alam, Mohammed Fasihul
    Elazzazy, Shereen
    Shafie, Asrul Akmal
    Hamad, Anas
    Ibrahim, Mohamed Izham Mohamed
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 (01)
  • [28] Cost-utility analysis of proton beam therapy for locally advanced esophageal cancer in Japan
    Sawada, Takuya
    Kondo, Masahide
    Goto, Masaaki
    Murakami, Motohiro
    Ishida, Toshiki
    Hiroshima, Yuichi
    Hoshi, Shu-Ling
    Okubo, Reiko
    Okumura, Toshiyuki
    Sakurai, Hideyuki
    PLOS ONE, 2024, 19 (09):
  • [29] Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung Cancer
    Lairson, David R.
    Parikh, Rohan C.
    Cormier, Janice N.
    Chan, Wenyaw
    Du, Xianglin L.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (06) : 271 - +
  • [30] SYSTEMIC THERAPY IN BREAST-CANCER - EFFICACY AND COST-UTILITY
    CORRY, JF
    LONNING, PE
    PHARMACOECONOMICS, 1994, 5 (03) : 198 - 212
12345